|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Engineering and medicine: Opportunities in type 1 diabetes
If you have a question about this talk, please contact Dr Jason Z JIANG.
The development of the artificial pancreas is underway with considerable stakeholders input and industry interest. Aimed to treat type 1 diabetes of all ages from early childhood to maturity, the artificial pancreas consists of a continuous glucose meter, control algorithm and an insulin pump. Significant life sciences opportunities exist to complement the clinical work and accelerate research progress and commercialisation of the artificial pancreas.
This talk is part of the CUED Control Group Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsFluid Mechanics (CUED) A Bridge to Freedom Shaping the Future - Cambridge Public Policy Lecture Series
Other talksArt of Transformation Group Discussions (Isaac Newton Institute & Centre for Mathematical Sciences) Myelination in development and learning Chemoproteomics and lipidomics reveal a new lipid hydrolase target in platelets Rambling in NE Mexico Seminar – Effects of Macronutrient Distribution on Weight Change and Related Cardiometabolic Profiles in Healthy Non-Obese Chinese: A Randomized, Clinical Trial